Nature Communications (Apr 2019)

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

  • Yan Li,
  • Roberto Tinoco,
  • Lisa Elmén,
  • Igor Segota,
  • Yibo Xian,
  • Yu Fujita,
  • Avinash Sahu,
  • Raphy Zarecki,
  • Kerrie Marie,
  • Yongmei Feng,
  • Ali Khateb,
  • Dennie T. Frederick,
  • Shiri K. Ashkenazi,
  • Hyungsoo Kim,
  • Eva Guijarro Perez,
  • Chi-Ping Day,
  • Rafael S. Segura Muñoz,
  • Robert Schmaltz,
  • Shibu Yooseph,
  • Miguel A. Tam,
  • Tongwu Zhang,
  • Emily Avitan-Hersh,
  • Lihi Tzur,
  • Shoshana Roizman,
  • Ilanit Boyango,
  • Gil Bar-Sela,
  • Amir Orian,
  • Randal J. Kaufman,
  • Marcus Bosenberg,
  • Colin R. Goding,
  • Bas Baaten,
  • Mitchell P. Levesque,
  • Reinhard Dummer,
  • Kevin Brown,
  • Glenn Merlino,
  • Eytan Ruppin,
  • Keith Flaherty,
  • Amanda Ramer-Tait,
  • Tao Long,
  • Scott N. Peterson,
  • Linda M. Bradley,
  • Ze’ev A. Ronai

DOI
https://doi.org/10.1038/s41467-019-09525-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 16

Abstract

Read online

RNF5 is a ubiquitin ligase regulating ER stress response. Here the authors show that Rnf5 deficiency potentiates immune response against melanoma via altered microbiota, and isolate bacterial strains that confer the same phenotype to wild type mice.